Literature DB >> 21652703

Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycans.

Atsushi Sekiya1, Hitomi Okano-Kosugi, Chisato M Yamazaki, Takaki Koide.   

Abstract

Pigment epithelium-derived factor (PEDF) is a collagen-binding protein that is abundantly distributed in various tissues, including the eye. It exhibits various biological functions, such as anti-angiogenic, neurotrophic, and neuroprotective activities. PEDF also interacts with extracellular matrix components such as collagen, heparan sulfate proteoglycans (HSPGs), and hyaluronan. The collagen-binding property has been elucidated to be important for the anti-angiogenic activity in vivo (Hosomichi, J., Yasui, N., Koide, T., Soma, K., and Morita, I. (2005) Biochem. Biophys. Res. Commun. 335, 756-761). Here, we investigated the collagen recognition mechanism by PEDF. We first narrowed down candidate PEDF-binding sequences by taking advantage of previously reported structural requirements in collagen. Subsequent searches for PEDF-binding sequences employing synthetic collagen-like peptides resulted in the identification of one of the critical binding sites for PEDF, human α1(I)(929-938) (IKGHRGFSGL). Further analysis revealed that the collagen recognition by PEDF is sequence- and conformation-specific, and the high affinity binding motif is KGXRGFXGL in the triple helix. The PEDF-binding motif significantly overlapped with the heparin/HSPG-binding motif, KGHRG(F/Y). The interaction of PEDF with collagen I was specifically competed with by heparin but not by chondroitin sulfate-C or hyaluronan. The binding sequences for PEDF and heparin/HSPG also overlapped with the covalent cross-linking sites between collagen molecules. These findings imply a functional relationship between PEDF and HSPGs during angiogenesis, and the interaction of these molecules is regulated by collagen modifications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652703      PMCID: PMC3143599          DOI: 10.1074/jbc.M111.252684

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature.

Authors:  G A Silverman; P I Bird; R W Carrell; F C Church; P B Coughlin; P G Gettins; J A Irving; D A Lomas; C J Luke; R W Moyer; P A Pemberton; E Remold-O'Donnell; G S Salvesen; J Travis; J C Whisstock
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

2.  Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF.

Authors:  Norihisa Yasui; Terumi Mori; Daisuke Morito; Osamu Matsushita; Hiroki Kourai; Kazuhiro Nagata; Takaki Koide
Journal:  Biochemistry       Date:  2003-03-25       Impact factor: 3.162

3.  Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity.

Authors:  Christina Meyer; Luigi Notari; S Patricia Becerra
Journal:  J Biol Chem       Date:  2002-09-16       Impact factor: 5.157

4.  Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor.

Authors:  M Simonovic; P G Gettins; K Volz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

5.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.

Authors:  L Pellegrini; D F Burke; F von Delft; B Mulloy; T L Blundell
Journal:  Nature       Date:  2000-10-26       Impact factor: 49.962

6.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.

Authors:  J Schlessinger; A N Plotnikov; O A Ibrahimi; A V Eliseenkova; B K Yeh; A Yayon; R J Linhardt; M Mohammadi
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

7.  Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization.

Authors:  Steen V Petersen; Zuzana Valnickova; Jan J Enghild
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

8.  Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor.

Authors:  Lin Wang; Volker Schmitz; Alberto Perez-Mediavilla; Iñigo Izal; Jesus Prieto; Cheng Qian
Journal:  Mol Ther       Date:  2003-07       Impact factor: 11.454

9.  Antithrombin III phenylalanines 122 and 121 contribute to its high affinity for heparin and its conformational activation.

Authors:  Mohamad Aman Jairajpuri; Aiqin Lu; Umesh Desai; Steven T Olson; Ingemar Bjork; Susan C Bock
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

10.  Glycosaminoglycans in human retinoblastoma cells: heparan sulfate, a modulator of the pigment epithelium-derived factor-receptor interactions.

Authors:  Elena M Alberdi; John E Weldon; S Patricia Becerra
Journal:  BMC Biochem       Date:  2003-02-19       Impact factor: 4.059

View more
  19 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

Review 2.  Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.

Authors:  Joan C Marini; Adi Reich; Simone M Smith
Journal:  Curr Opin Pediatr       Date:  2014-08       Impact factor: 2.856

3.  Spatiotemporal regulation of PEDF signaling by type I collagen remodeling.

Authors:  Kazuki Kawahara; Takuya Yoshida; Takahiro Maruno; Hiroya Oki; Tadayasu Ohkubo; Takaki Koide; Yuji Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-08       Impact factor: 11.205

Review 4.  Regulators of collagen crosslinking in developing and adult tendons.

Authors:  A J Ellingson; N M Pancheri; N R Schiele
Journal:  Eur Cell Mater       Date:  2022-04-05       Impact factor: 4.325

Review 5.  Osteogenesis imperfecta.

Authors:  Antonella Forlino; Joan C Marini
Journal:  Lancet       Date:  2015-11-03       Impact factor: 79.321

6.  Molecular underpinnings of integrin binding to collagen-mimetic peptides containing vascular Ehlers-Danlos syndrome-associated substitutions.

Authors:  Cody L Hoop; Allysa P Kemraj; Baifan Wang; Sonal Gahlawat; Madison Godesky; Jie Zhu; Haley R Warren; David A Case; David I Shreiber; Jean Baum
Journal:  J Biol Chem       Date:  2019-08-12       Impact factor: 5.157

Review 7.  Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.

Authors:  Milena Jovanovic; Gali Guterman-Ram; Joan C Marini
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

Review 8.  Proteomic database mining opens up avenues utilizing extracellular protein phosphorylation for novel therapeutic applications.

Authors:  Garif Yalak; Bjorn R Olsen
Journal:  J Transl Med       Date:  2015-04-19       Impact factor: 5.531

9.  Mutations and altered expression of SERPINF1 in patients with familial otosclerosis.

Authors:  Joanna L Ziff; Michael Crompton; Harry R F Powell; Jeremy A Lavy; Christopher P Aldren; Karen P Steel; Shakeel R Saeed; Sally J Dawson
Journal:  Hum Mol Genet       Date:  2016-04-07       Impact factor: 6.150

10.  Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor Functions as a Receptor Inhibitor.

Authors:  Bo An; Vittorio Abbonante; Huifang Xu; Despoina Gavriilidou; Ayumi Yoshizumi; Dominique Bihan; Richard W Farndale; David L Kaplan; Alessandra Balduini; Birgit Leitinger; Barbara Brodsky
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.